首页> 外文OA文献 >Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease
【2h】

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

机译:缺乏供体Th17会导致Th1分化增强并加剧急性移植物抗宿主病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Th17 is a newly identified T-cell lineage that secretes proinflammatory cytokine IL-17. Th17 cells have been shown to play a critical role in mediating autoimmune diseases such as EAE, colitis, and arthritis, but their role in the pathogenesis of graft-versus-host disease (GVHD) is still unknown. Here we showed that, in an acute GVHD model of C57BL/6 (H-2b) donor to BALB/c (H-2d) recipient, IL-17−/− donor T cells manifested an augmented Th1 differentiation and IFN-γ production and induced exacerbated acute GVHD. Severe tissue damage mediated by IL-17−/− donor T cells was associated with increased Th1 infiltration, up-regulation of chemokine receptors by donor T cells, and enhanced tissue expression of inflammatory chemokines. Administration of recombinant IL-17 and neutralizing IFN-γ in the recipients given IL-17−/− donor cells ameliorated the acute GVHD. Furthermore, the regulation of Th1 differentiation by IL-17 or Th17 may be through its influence on host DCs. Our results indicate that donor Th17 cells can down-regulate Th1 differentiation and ameliorate acute GVHD in allogeneic recipients, and that treatments neutralizing proinflammatory cytokine IL-17 may augment acute GVHD as well as other inflammatory autoimmune diseases.
机译:Th17是新发现的T细胞谱系,可分泌促炎性细胞因子IL-17。已显示Th17细胞在介导自身免疫性疾病(例如EAE,结肠炎和关节炎)中起关键作用,但在移植物抗宿主病(GVHD)的发病机理中的作用仍然未知。在这里,我们显示,在C57BL / 6(H-2b)供体对BALB / c(H-2d)受体的急性GVHD模型中,IL-17-/-供体T细胞表现出Th1分化增强和IFN-γ产生并导致急性GVHD恶化。 IL-17-/-供体T细胞介导的严重组织损伤与Th1浸润增加,供体T细胞上调趋化因子受体上调以及炎性趋化因子的组织表达增强有关。在给予IL-17-/-供体细胞的受体中给予重组IL-17和中和IFN-γ可改善急性GVHD。此外,IL-17或Th17对Th1分化的调节可能是由于其对宿主DC的影响。我们的结果表明,供体Th17细胞可以下调Th1分化并改善同种异体受体的急性GVHD,中和促炎细胞因子IL-17的治疗可能会增强急性GVHD以及其他炎性自身免疫性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号